Formic Acid

Formic Acid

SCHEMBL237482

CCCC[P+](CCCC)(CCCC)CCCC.O=C[O-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 2/20 0.57
TSHR P16473 4/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CA2 P00918 5/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
FDPS P14324 1/20 0.37
ADH1B P00325 2/20 0.37
ADH1C P00326 2/20 0.37
ADH1A P07327 2/20 0.37
ADH7 P40394 2/20 0.37
ADH4 P08319 1/20 0.37
MAPK1 P28482 1/20 0.36
BDKRB2 P30411 1/20 0.35
TRPA1 O75762 1/20 0.35
DDAH1 O94760 1/20 0.35
GAPDH P04406 1/20 0.35
MAPT P10636 1/20 0.35
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL1767818 0.90 DNM1 (0.67) DNM1TSHRSMN1; SMN2CA2ADH1B
Furan SCHEMBL28711814 0.83 DNM1 (0.41) DNM1TSHRSMN1; SMN2MAPK1BDKRB2
Formic Acid SCHEMBL1031759 0.82 DNM1 (0.35) DNM1TSHRSMN1; SMN2ALDH1A1CYP3A4
SCHEMBL2864120 0.82 DNM1 (0.71) DNM1TSHRSMN1; SMN2CA2ALDH1A1
SCHEMBL29496398 0.82 DNM1 (0.80) DNM1TSHRSMN1; SMN2CA2ALDH1A1
Formic Acid SCHEMBL10753868 0.81 TSHR (0.46) DNM1TSHRSMN1; SMN2CA2ALDH1A1
Formic Acid SCHEMBL10926509 0.80 DNM1 (0.38) DNM1TSHRSMN1; SMN2CA2FDPS
SCHEMBL4447635 0.80 DNM1 (0.60) DNM1TSHRSMN1; SMN2CA2ALDH1A1
Phosphoric Acid SCHEMBL9063702 0.80 DNM1 (0.60) DNM1TSHRSMN1; SMN2CA2CYP3A4
Phosphoric Acid SCHEMBL266936 0.80 DNM1 (0.60) DNM1TSHRSMN1; SMN2CA2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108148394-B Storage-stable one-component polyurethane prepregs from polyurethane compositions and moldings produced therefrom 赢创运营有限公司 2021-12-28 CN claimed
EP-3330311-B1 STORAGE STABLE 1K-POLYURETHANE-PREPREGS AND MOULDED ARTICLE MADE FROM SAME ON THE BASIS OF A POLYURETHANE COMPOSITION EVONIK OPERATIONS GMBH (DE) 2021-05-05 EP claimed
US-10633519-B2 Storage-stable polyurethane prepregs and mouldings produced therefrom composed of a polyurethane composition with liquid resin components EVONIK OPERATIONS GMBH (DE) 2020-04-28 US claimed
US-10626236-B2 Storage-stable one-component polyurethane prepregs and shaped bodies composed of polyurethane composition that have been produced therefrom EVONIK OPERATIONS GMBH (DE) 2020-04-21 US claimed
US-10246558-B2 Compositions comprising siloxane compounds and methods for using the same MILLIKEN & COMPANY (US) 2019-04-02 US claimed
EP-3458498-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME Milliken & Company (US) 2019-03-27 EP claimed
US-20180155515-A1 STORAGE-STABLE ONE-COMPONENT POLYURETHANE PREPREGS AND SHAPED BODIES COMPOSED OF POLYURETHANE COMPOSITION THAT HAVE BEEN PRODUCED THEREFROM EVONIK OPERATIONS GMBH (DE) 2018-06-07 US claimed
WO-2017201035-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME MILLIKEN & COMPANY (US) 2017-11-23 WO claimed
US-20170335065-A1 COMPOSITIONS COMPRISING SILOXANE COMPOUNDS AND METHODS FOR USING THE SAME MILLIKEN & COMPANY 2017-11-23 US claimed
EP-2411439-B1 PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE EVONIK DEGUSSA GMBH (DE) 2016-11-16 EP claimed
US-8455090-B2 Prepegs and molded bodies produced thereof at low temperature EVONIK DEGUSSA GMBH (DE) 2013-06-04 US claimed
US-20120003890-A1 PREPEGS AND MOLDED BODIES PRODUCED THEREOF AT LOW TEMPERATURE EVONIK DEGUSSA GMBH (DE) 2012-01-05 US claimed
US-20100249310-A1 REACTIVE ISOCYANATE COMPOSITIONS EVONIK DEGUSSA GMBH (DE) 2010-09-30 US claimed
US-20100227942-A1 DUAL-CURE FORMULATIONS WITH COMPONENTS CONTAINING URETDIONE GROUPS EVONIK DEGUSSA GMBH (DE) 2010-09-09 US claimed
EP-2174969-A1 RESIN COMPOSITION Ajinomoto Co., Inc. (JP) 2010-04-14 EP claimed
US-20090030158-A1 RESIN COMPOSITION AJINOMOTO CO., INC (JP) 2009-01-29 US claimed
US-20080196626-A1 High silicon-content resin composition used to form thin film thermosets; form low k dielectric constant materials; hard mask and underlayer materials with anti-reflective properties for photolithography industry MERCK PATENT GMBH (DE) 2008-08-21 US claimed
US-20080139753-A1 Highly Reactive Uretdione Group-Containing Polyurethane Compositions Based on 1,4-Diisocyanato-Dicyclohexyl Methane DEGUSSA GMBH (DE) 2008-06-12 US claimed
US-20080097025-A1 Highly Reactive Polyurethane Compositions Containing Uretdione Groups DEGUSSA GMBH (DE) 2008-04-24 US claimed
US-20050239956-A1 Polyurethane composition which contains an uretdione group DEGUSSA AG (DE) 2005-10-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030158-A1 RESIN COMPOSITION PPA1, PTGER1, TAF5 DNM1 4194/4885TSHR 3221/4885SMN1; SMN2 1591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.